EUVIMEDEUVIMED entdecken
Fallbericht

Interleukin-36 receptor antagonist deficiency patient with a novel mutation

Müge Sezer, Fatma Aydın, Eda Özaydın, Elif Çelikel, Ahu Yorulmaz, Resul Karakuş, Banu Acar

Archives de Pédiatrie · 2026

DOI: 10.1016/j.arcped.2025.12.005 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Archives de Pédiatrie, 2026. Verfasst von Müge Sezer und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Health Sciences, Ankara Training and Education Hospital, Department of Pediatric Rheumatology, Ankara, Turkey. Electronic address: muge…. Hauptthemen laut MEDLINE: Interleukins, Psoriasis. Die Arbeit nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The deficiency of interleukin-36 receptor antagonist (DITRA) is a monogenic autoinflammatory condition associated with generalized pustular psoriasis (GPP). Diagnostic criteria and treatment recommendations for DITRA are inadequate. The diagnosis is established by detecting a biallelic loss-of-function mutation in IL36RN, which leads to activation of the IL36 pathway. OBSERVATION AND DISCUSSION: We present a pediatric case of GPP with a novel IL36RN mutation that supports the diagnosis of DITRA. In patients with DITRA unresponsive to IL-1 targeted therapies, favorable results may be achieved with the administration of TNF-α inhibitors, particularly IL-36 pathway inhibitors. Twenty-nine papers, encompassing 55 pediatric cases, were synthesized to contextualize treatment responses. CONCLUSION: Novel DITRA-associated mutations continue to be discovered. Given the rarity of the disease, it will be possible to reveal the genotype-phenotype relationship in the future with the publication of larger DITRA case series.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InterleukinsPsoriasisHumansMaleMutationChild, Preschool

Stichwörter der Autor:innen

Autoinflammatory disorderDITRADeficiency of interleukin-36 receptor antagonistgeneralized pustular psoriasis, TNF-α inhibitors

Substanzen

IL36RN protein, humanInterleukins

Autor:innen und Institutionen

  • University of Health Sciences, Ankara Training and Education Hospital, Department of Pediatric Rheumatology, Ankara, Turkey. Electronic address: muge2202@hotmail.com.
  • Ankara University Faculty of Medicine, Department of Pediatric Rheumatology, Ankara, Turkey.
  • University of Health Sciences, Ankara City Hospital, Department of Pediatric, Ankara, Turkey.
  • University of Health Sciences, Ankara City Hospital, Department of Pediatric Rheumatology, Ankara, Turkey.
  • University of Health Sciences, Ankara City Hospital, Department of Dermatology, Ankara, Turkey.
  • Gazi University Faculty of Medicine, Department of Immunology, Ankara, Turkey.

Zitieren

APA

Sezer, M., Aydın, F., Özaydın, E., Çelikel, E., Yorulmaz, A., Karakuş, R., & Acar, B. (2026). Interleukin-36 receptor antagonist deficiency patient with a novel mutation. Archives de Pédiatrie. https://doi.org/10.1016/j.arcped.2025.12.005

Vancouver

Sezer M, Aydın F, Özaydın E, Çelikel E, Yorulmaz A, Karakuş R, et al. Interleukin-36 receptor antagonist deficiency patient with a novel mutation. Archives de Pédiatrie. 2026. doi:10.1016/j.arcped.2025.12.005

BibTeX
@article{Sezer2026,
  author = {Sezer, Müge and Aydın, Fatma and Özaydın, Eda and Çelikel, Elif and Yorulmaz, Ahu and Karakuş, Resul and Acar, Banu},
  title = {Interleukin-36 receptor antagonist deficiency patient with a novel mutation},
  journal = {Archives de Pédiatrie},
  year = {2026},
  doi = {10.1016/j.arcped.2025.12.005}
}
Kostenlos starten →